International Journal of Clinical Pharmacy

, Volume 34, Issue 3, pp 460–467 | Cite as

Impact of an interactive workshop on community pharmacists’ beliefs toward patient care

  • Lisa M. GuirguisEmail author
  • Shao Lee
  • Ravina Sanghera
Research Article


Background Patient assessment and documentation are less than optimal in pharmacy practice as preparing and dispensing medications is still a major part of community pharmacy practice. Pharmacists’ attitudes, specifically self-efficacy and role beliefs, toward practice have been shown to predict practice change. Objective This study will determine the impact of an interactive workshop on pharmacists’ attitudes toward assessment and documentation in routine pharmacy practice. Specific objectives included how (1) pharmacists’ role beliefs and self-efficacy toward assessment and documentation change after training and rehearsal and (2) frequently do pharmacists assess patient therapy and document patient care? Setting: “Chat, Check and Chart: patient assessment and documentation demystified” workshop Alberta College of Pharmacists Annual General Meeting in Calgary, Canada. Methods This study is pre–post evaluation. Quantitative data on self-efficacy and role beliefs toward assessment and documentation was gathered from a validated written survey. Surveys were completed before and after the intervention. The intervention, an interactive workshop, focused on the use of three tools practice and was designed to support pharmacists in achieving the assessment and documentation required by the Alberta College of Pharmacists Standards for Practice. Main outcome measure: Pharmacists’ role beliefs and self-efficacy toward assessment and documentation in patient care. Results Of the 61 eligible pharmacists, the response rate was 61 % (37 pharmacists) with complete data. In the past 2 weeks, 54 % of pharmacists were assessing patients and 32.6 % of pharmacists were documenting greater than half the time. Prior to the workshop, pharmacists “agreed” (5.42 ± 1.41) with their role in patient assessment and they were “quite sure” (4.75 ± 1.10) they could assess patients. Pharmacists “agreed” (5.13 ± 0.890) with their overall role in documentation of patient interactions and reported lower self-efficacy (3.88 ± 1.32) for their ability to document patient interactions. After the interactive workshop, there were statistically significant increases in pharmacists’ self-efficacy and role beliefs in regards to both patient assessment and documentation (p < 0.05). Conclusion This brief interactive workshop increased both self-efficacy and role beliefs towards assessment and documentation, indicating these pharmacists are likely to change future practice. Future research will assess practice uptake and implementation.


Community pharmacy Documentation Intervention Patient assessment Pharmacist Pharmacist role-beliefs Pharmacist self-efficacy Pharmacist training 



Anita Cumbleton and Andrew Wong, pharmacy students from the University of Alberta, Canada, were instrumental in conducting the research and analysis.


We would like to acknowledge the Alberta College of Pharmacists for supporting the training workshop.

Conflicts of interest



  1. 1.
    Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017–25.PubMedCrossRefGoogle Scholar
  2. 2.
    Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE. 2009;4(2):e4439.PubMedCrossRefGoogle Scholar
  3. 3.
    Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a canadian hospital: a prospective study. Pharmacotherapy. 2006;26(11):1578–86.PubMedCrossRefGoogle Scholar
  4. 4.
    Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Thinking outside the pillbox. A system-wide approach to improving patient medication adherence for chronic disease. Cambridge: New England Healthcare Institute; 2009.Google Scholar
  6. 6.
    Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.Google Scholar
  7. 7.
    Avorn J, Shrank WH. Adverse drug reactions in elderly people: a substantial cause of preventable illness. BMJ. 2008;336(7650):956–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;41(9):1411–26.PubMedCrossRefGoogle Scholar
  9. 9.
    Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int. 2010;5:391–8.CrossRefGoogle Scholar
  10. 10.
    Yamada C, Johnson JA, Robertson P, Pearson G, Tsuyuki RT. Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Pharmacotherapy. 2005;25(1):110–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus). Am J Med. 2004;116(2):130–3.PubMedCrossRefGoogle Scholar
  12. 12.
    Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162(10):1149–55.PubMedCrossRefGoogle Scholar
  13. 13.
    Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. Int J Pharm Pract. 2005;13:53–70.CrossRefGoogle Scholar
  14. 14.
    Hughes CA, Guirguis LM, Wong T, Ng K, Ing L, Fisher K. Influence of pharmacy practice on community pharmacists’ integration of medication and lab value information from electronic health records. J Am Pharm Assoc. 2003;51(5):591–8.CrossRefGoogle Scholar
  15. 15.
    Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across europe. Pharm World Sci. 2010;32(4):472–87.PubMedCrossRefGoogle Scholar
  16. 16.
    Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy’s claims to professional status in the united kingdom. Res Soc Adm Pharm. 2009;5(4):305–18.CrossRefGoogle Scholar
  17. 17.
    Jones EJ, MacKinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.PubMedCrossRefGoogle Scholar
  18. 18.
    Bonfiglio MF, Lewis JD, Nesbit SA, Krinsky DL. A contemporary perspective on pharmacy’s traditional strengths. J Am Pharm Assoc. 1997;NS37(6):700–4.Google Scholar
  19. 19.
    Galt KA, Narducci WA. Integrated pharmaceutical care services: the product is part of the care. Pharmacotherapy. 1997;17(4):841–4.PubMedGoogle Scholar
  20. 20.
    Martinez Sanchez A, Campos RM. Detection of prescribing related problems at the community pharmacy. Int J Clin Pharm. 2011;33(1):66–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Braund R, Furlan HM, George K, Havell MM, Murphy JL, West MK. Interventions performed by new zealand community pharmacists while dispensing prescription medications. Pharm World Sci. 2010;32(1):22–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Ekedahl A. Problem prescriptions in Sweden necessitating contact with the prescriber before dispensing. Res Soc Adm Pharm. 2010;6(3):174–84.CrossRefGoogle Scholar
  23. 23.
    Krahenbuhl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30(6):777–86.PubMedCrossRefGoogle Scholar
  24. 24.
    Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695–700.PubMedCrossRefGoogle Scholar
  25. 25.
    Mandt I, Horn AM, Ekedahl A, Granas AG. Community pharmacists’ prescription intervention practices—Exploring variations in practice in Norwegian pharmacies. Res Soc Adm Pharm. 2010;6(1):6–17.CrossRefGoogle Scholar
  26. 26.
    Deschamps M, Dyck A, Taylor J. What are we saying? Content and organization of patient counseling by community pharmacists. Can Pharm J. 2003;136(6):42–7.Google Scholar
  27. 27.
    Martin BA, Bruskiewitz RH, Chewning BA. Effect of a tobacco cessation continuing professional education program on pharmacists’ confidence, skills, and practice-change behaviors. J Am Pharm Assoc. 2003;50(1):9–16.CrossRefGoogle Scholar
  28. 28.
    Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender, and patient question asking behavior with the content of pharmacist-patient communication. Pharm Res. 1997;14(2):145–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Anonymous. Pharmacist-patient consultation program (PPCP-1): an interactive approach to patient consultation. New York, NY: Pfizer Inc.; 2002.Google Scholar
  30. 30.
    Berger BA. Communication skills for pharmacists: building relationships, improving care. Washington DC: American Pharmaceutical Association; 2009.Google Scholar
  31. 31.
    Beardsley RS, Kimberlin CL, Tindall WN. Communication skills in pharmacy practice. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.Google Scholar
  32. 32.
    Cipolle RJ, Strand LM, Morley PC, Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the clinician’s guide. 2nd ed. New York: McGraw-Hill Medical; 2004.Google Scholar
  33. 33.
    Farrell B, Kennie NR, Dolovich LR. Demonstrating value, documenting care: lessons learned about writing comprehensive patient medication assessments in the IMPACT project: part II. Can Pharm J. 2008;141(3):182–8.CrossRefGoogle Scholar
  34. 34.
    Guirguis LM, Chewning BA. Development of a measure to assess pharmacy students’ beliefs about monitoring chronic diseases. Res Soc Adm Pharm. 2008;4(4):402–16.CrossRefGoogle Scholar
  35. 35.
    Farris KB, Schopflocher DP. Between intention and behavior: an application of community pharmacists’ assessment of pharmaceutical care. Soc Sci Med. 1999;49(1):55–66.PubMedCrossRefGoogle Scholar
  36. 36.
    Miller GE. The assessment of clinical skills/competence/performance. Acad Med. 1990;65(9 Suppl):S63–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.PubMedCrossRefGoogle Scholar
  38. 38.
    Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: quantifying the needs of community pharmacies. Res Soc Adm Pharm. 2010;6(3):163–73.CrossRefGoogle Scholar
  39. 39.
    Bright DR, Lengel AJ, Powers MF. Pharmacists’ perceptions of barriers to implementing medication therapy management and the role of pharmacy technicians in overcoming the barriers. J Pharm Technol [Internet]. 2009;25:361–7.Google Scholar
  40. 40.
    Zardain E, del Valle MO, Loza MI, Garcia E, Lana A, Markham WA, et al. Psychosocial and behavioural determinants of the implementation of pharmaceutical care in Spain. Pharm World Sci. 2009;31(2):174–82.PubMedCrossRefGoogle Scholar
  41. 41.
    McCaig D, Fitzgerald N, Stewart D. Provision of advice on alcohol use in community pharmacy: a cross-sectional survey of pharmacists’ practice, knowledge, views and confidence. Int J Pharm Pract. 2011;19(3):171–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Warholak TL, Rupp MT. Analysis of community chain pharmacists’ interventions on electronic prescriptions. J Am Pharm Assoc. 2003;49(1):59–64.CrossRefGoogle Scholar
  43. 43.
    Lee I. Comparison of patients’ perceptions to pharmacists’ perceptions of pharmacy counseling. J Am Pharm Assoc. 2005;45(2):251.Google Scholar
  44. 44.
    Hirsch JD, Oen A, Robertson S, Nguyen N, Daniels C. Patient request for pharmacist counseling and satisfaction: automated prescription delivery system versus regular pick-up counter. J Am Pharm Assoc. 2003;49(1):73–7.CrossRefGoogle Scholar
  45. 45.
    Chewning BA, Patwardhan PD. Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract. 2009;17(9):221–9.PubMedGoogle Scholar
  46. 46.
    Floor-Schreudering A, De Smet PA, Buurma H, Egberts AC, Bouvy ML. Documentation quality in community pharmacy: completeness of electronic patient records after patients’ first visits. Ann Pharmacother. 2009;43(11):1787–94.PubMedCrossRefGoogle Scholar
  47. 47.
    Brock KA, Casper KA, Green TR, Pedersen CA. Documentation of patient care services in a community pharmacy setting. J Am Pharm Assoc. 2006;46(3):378–84.CrossRefGoogle Scholar
  48. 48.
    Angelo LB, Christensen DB, Ferreri SP. Impact of community pharmacy automation on workflow, workload, and patient interaction. J Am Pharm Assoc. 2005;45(2):138–44.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Faculty of Pharmacy and Pharmaceutical Sciences 3-171, Edmonton Clinic Health AcademyUniversity of AlbertaEdmontonCanada
  2. 2.Alberta College of PharmacistsEdmontonCanada

Personalised recommendations